Cymex is an Indian pharmaceutical company headquartered in Hyderabad, Telangana, India. Established in 2018 the company is an end-to-end solutions provider of APIs and advanced intermediates to the pharmaceutical industry. .
The company has a presence in 10 therapeutic categories, including Antiretrovirals, cardiovascular, central nervous systems, arthritis, anti-fungal, anti-invectives, anticoagulant and diabetes .
The company’s major business segments comprise:
Active Pharmaceutical Ingredients
The company manufactures APIs for leading pharmaceutical companies worldwide.
Designing and developing manufacturing processes
Filing DMFs/CMCs for APIs
Cymex was built with a motivated, long-term vision
Quality:
Steady commitment to quality in all the way – from building state-of-the-art facilities and technology, to employees being trained to maintain highest quality and regulatory values
Reliability:
Robust motto of transparency and upright business morals form the basis of the organization
Team Work:
Quality and trust built on our philosophy. The way we work teamwork and with our associates trust, transparency and close partnership
We develop and manufacture pharmaceuticals that comply with the highest regulatory standards.
We meet current and future customer needs through smart investments in R&D.
We deliver best-in-class service and superior value.
We celebrate the many cultures of our global team.
We enhance the communities in which we live and work.
We build shareholder value in all we do.